💊📢

AUROPHARMA

| Company Update

🚫 The company has denied media reports regarding a USD 5.5 billion Zentiva buyout. 📌 Clarified that no binding agreement has been reached. ⚡ Market takeaway: Investors can breathe easy as Aurobindo distances itself from speculation and focuses on its core growth strategy.